Jump to content

Felvizumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Fswitzer4 (talk | contribs) at 00:04, 20 February 2022 (Added UNII). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Felvizumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetRSV
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
 ☒NcheckY (what is this?)  (verify)

Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.[1][2]

References

  1. ^ "WHO Drug Information" (PDF). Archived from the original (PDF) on February 23, 2012.
  2. ^ Milne GW (2018). "6591: Felvizumab". Drugs synonyms and properties. London: Routledge Revivals. ISBN 978-1-351-78989-9.


Stub icon

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Felvizumab&oldid=1072887385"